Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, December 21, 2023

Antioxidant and Anti-Inflammatory Effects of Garlic in Ischemic Stroke: Proposal of a New Mechanism of Protection through Regulation of Neuroplasticity

You'll have to ask your competent doctor the amounts for this. You do have a competent doctor don't you?

But then your  competent doctor has been prescribing garlic for over ten years now, right?

Garlic intake is an independent predictor of endothelial function in patients with ischemic stroke April 2013

The latest here:

Antioxidant and Anti-Inflammatory Effects of Garlic in Ischemic Stroke: Proposal of a New Mechanism of Protection through Regulation of Neuroplasticity 

2, 2,3, 1,4, 1 and 1,2,*
1
Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico
2
Laboratorio de Patología Vascular Cerebral, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City 14269, Mexico
3
Servicio de Cirugía General, Hospital General de Zona #30, Instituto Mexicano del Seguro Social, Mexico City 08300, Mexico
4
Departamento Cirugía General, Hospital Central Militar, Mexico City 11600, Mexico
*
Author to whom correspondence should be addressed.
Antioxidants 2023, 12(12), 2126; https://doi.org/10.3390/antiox12122126
Submission received: 26 October 2023 / Revised: 2 December 2023 / Accepted: 14 December 2023 / Published: 16 December 2023
(This article belongs to the Special Issue Oxidative Stress and Pathophysiology of Stroke)

Abstract

Stroke represents one of the main causes of death and disability in the world; despite this, pharmacological therapies against stroke remain insufficient. Ischemic stroke is the leading etiology of stroke. Different molecular mechanisms, such as excitotoxicity, oxidative stress, and inflammation, participate in cell death and tissue damage. At a preclinical level, different garlic compounds have been evaluated against these mechanisms. Additionally, there is evidence supporting the participation of garlic compounds in other mechanisms that contribute to brain tissue recovery, such as neuroplasticity. After ischemia, neuroplasticity is activated to recover cognitive and motor function. Some garlic-derived compounds and preparations have shown the ability to promote neuroplasticity under physiological conditions and, more importantly, in cerebral damage models. This work describes damage/repair mechanisms and the importance of garlic as a source of antioxidant and anti-inflammatory agents against damage. Moreover, we examine the less-explored neurotrophic properties of garlic, culminating in proposals and observations based on our review of the available information. The aim of the present study is to propose that garlic compounds and preparations could contribute to the treatment of ischemic stroke through their neurotrophic effects.

Graphical Abstract

1. Introduction

Stroke significantly impacts a large segment of the population and stands as one of the leading causes of death and disability. Currently, fibrinolytics and endovascular therapies that induce reperfusion are the only treatments available, yet they are often insufficient and can even result in further brain damage. Consequently, research is focused on identifying new therapeutic targets and protective molecules. Key mechanisms implicated in ischemic stroke-related injury include excitotoxicity, oxidative stress, and inflammation. Numerous molecules demonstrate potent antioxidant and anti-inflammatory properties; however, they frequently fail in clinical trials as effective stroke treatments. On the other hand, there are repair mechanisms such as neuroplasticity that are potential targets for ischemic stroke treatment. Neuroplasticity is a repair mechanism that comprises changes that generate new cells and synaptic connections. Thus, the discovery of novel mechanisms related to recovery in therapeutic stroke research is essential. Garlic and its preparations are a source of antioxidant, anti-inflammatory, and neurotrophic molecules. Hence, the aim of this review is to analyze the neurotrophic properties of garlic compounds and preparations as a possible management method for ischemic stroke.

2. Stroke

2.1. Stroke Epidemiology and Risk Factors

Amongst neurological diseases, stroke represents one of the leading causes of death and disability worldwide [1]. Furthermore, people affected by stroke require temporary or lifelong assistance, resulting in a huge burden at the human and economic cost levels [2,3].
Stroke is classified into ischemic and hemorrhagic, with a higher prevalence of the ischemic condition. Ischemic stroke occurs when the blood supply decreases under the tissue demand requirements for normal function, resulting in deficiencies in oxygen, glucose, and other molecules required for brain metabolism [4].
Despite the heterogeneity of this disease, some non-modifiable risk factors such as age and gender contribute importantly to the incidence of ischemic stroke. Aging is the strongest non-modifiable risk factor; three quarters of all strokes occur in persons aged >65 years, and the risk doubles every 10 years after the age of 55 [5,6,7]. Moreover, aged patients with stroke have higher mortality and morbidity rates and present poorer functional recovery than their young counterparts [5,6,7]. It is estimated that the increase in the size of the aged population represents an important factor that will contribute to the increase in ischemic stroke cases in the future [8]. Additionally, gender also is an important factor contributing to the incidence, mortality, and after-effects associated with stroke [9]. After the age of 65, the risk of suffering a stroke is increased in women compared with men of the same age [9,10,11]. Other clinical studies observed that older women experience more severe strokes, longer periods of hospitalization, more severe sequelae, and lower quality of life relative to men of similar ages [10,11].
 
More at link.

No comments:

Post a Comment